Last week, Novant Health known as off its plans to buy two North Carolina hospitals from Community Health Systems (CHS), which is likely one of the nation’s largest for-profit hospital chains. The choice got here after an appellate courtroom granted the Federal Trade Commission an emergency injunction to block the $320 million deal.
Novant — based mostly in Winston-Salem, North Carolina — contains 19 hospitals and greater than 850 outpatient care places. In February 2023, the well being system introduced its plans to purchase two CHS hospitals in North Carolina: Lake Norman Regional Medical Center, a 123-bed acute care hospital in Mooresville; and Davis Regional Medical Center in Statesville, which was a 146-bed acute care hospital earlier than its closed in 2022 to transition right into a behavioral well being hospital.
The FTC had been making an attempt to block the deal for months, arguing that it will damage competitors and lift costs in Charlotte’s northern suburbs. The company, which sued to block the deal in January, stated that the proposed deal would enable Novant to management almost 65% of the inpatient common acute care companies market within the Eastern Lake Norman Area of those northern suburbs.
Earlier, this month, a district courtroom dominated twice in Novant’s favor, saying that the 2 CHS hospitals would seemingly have to shut down with out the deal.
But final week, an appellate courtroom granted the FTC’s request for a brief injunction blocking the sale. The injunction would stop Novant and CHS from finalizing their deal till the attraction course of was finished, which may take greater than two years.
For Novant and CHS, this was the ultimate nail within the coffin.
“Novant Health has labored tirelessly for greater than a 12 months to create a path ahead for Lake Norman Regional Medical Center and Davis Regional Medical Center. Despite our imaginative and prescient to restore companies the world has misplaced and ship top quality, exceptional care, we’ve been met with opposition from the Federal Trade Commission at each step,” a Novant spokesperson wrote in a press release offered to MedCity News.
Novant continues to be steadfast in its perception that the 2 hospitals would have “vastly benefited” from becoming a member of its well being system, however the group doesn’t see a means to finalize the transaction given the FTC’s continued roadblocks, the spokesperson added.
In a press release launched final week, CHS stated it’s within the means of evaluating the present operations at its two hospitals in mild of the deal’s cancellation. The well being system assured sufferers that there will likely be no disruptions to healthcare companies on the two amenities.
The three-judge panel’s ruling in the end precipitated the acquisition to collapse, however the choice wasn’t unanimous. U.S. Circuit Judge Harvie Wilkinson represented the minority of the 2-1 ruling.
Wilkinson wrote that he might have despatched the deal again to the FTC if it have been “a merger between two behemoths.” However, to him, the FTC was “performing too aggressively” and “forgetting there may be such a factor as a vibrant non-public sector.”
Nathan Ray, accomplice of healthcare and life sciences at West Monroe, agreed with Wilkinson.
“The choice highlights the numerous value and time uncertainties launched by FTC involvement, even after a latest favorable judgment,” he wrote in a press release despatched to MedCity News. “The FTC’s efforts to decelerate offers create extra uncertainty, main corporations to rethink their plans moderately than threat extended authorized battles. This transfer suggests comparable offers would possibly face the identical challenges sooner or later. The FTC’s present strategy as it’s creating extra uncertainty, which isn’t a constructive final result for any events concerned.”
Photo: AndreyPopov, Getty Images